OBI Pharma, Inc. (TPEX:4174)

OBI Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 14, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	15,831	15,910	15,831	22,680	26,213	24,833
Market Cap Growth	-6.74%	0.50%	-30.20%	-13.48%	5.56%	-8.35%
Enterprise Value	15,967	14,396	12,411	21,039	22,895	20,239
Last Close Price	60.20	68.99	68.69	112.19	136.79	129.91
PS Ratio	198.46	382.92	3360.52	1208.19	186.06	4445.58
PB Ratio	5.83	3.21	2.58	5.86	5.42	4.19
P/TBV Ratio	7.59	4.26	3.73	9.79	6.94	4.93
EV/Sales Ratio	229.58	346.49	2634.54	1120.77	162.51	3623.12
Debt / Equity Ratio	0.14	0.11	0.05	0.08	0.05	0.05
Asset Turnover	0.01	0.01	0.00	0.00	0.02	0.00
Inventory Turnover	5.53	4.80	2.84	5.24	1.12	-
Quick Ratio	9.86	17.73	21.71	8.18	15.05	23.38
Current Ratio	11.70	19.92	22.76	8.72	15.67	23.97
Return on Equity (ROE)	-51.23%	-22.83%	-37.96%	-39.45%	-27.69%	-32.99%
Return on Assets (ROA)	-26.34%	-21.35%	-23.86%	-21.83%	-15.49%	-17.61%
Return on Capital (ROIC)	-26.80%	-21.90%	-25.05%	-23.20%	-16.24%	-18.36%
Earnings Yield	-13.31%	-6.58%	-10.19%	-6.75%	-5.26%	-5.67%
FCF Yield	-12.57%	-11.03%	-11.84%	-5.76%	-6.84%	-4.78%
Buyback Yield / Dilution	-0.09%	-3.12%	-11.65%	-0.18%	-3.56%	-10.80%
Total Shareholder Return	-0.09%	-3.12%	-11.65%	-0.18%	-3.56%	-10.80%

Source: S&P Capital IQ. Standard template. Financial Sources.